We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Deaths Prompt Warnings On Rituxan

Law360 (December 19, 2006, 12:00 AM EST) -- The U.S. Food and Drug Administration and the drug makers are warning the public that two patients who have taken non-Hodgkins lymphoma and rheumatoid arthritis drug Rituxan have died from a rare nervous system disease.

The FDA said Monday that the patients were taking the drug for systemic lupus erythematosus and developed progressive multifocal leukoencephalopathy or PML, which is a fatal viral infection of the central nervous system. The patients reported the infection as late as a year after their last doses of the drug....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.